TW

Thomas Weimer

CA Csl Behring Ag: 13 patents #2 of 160Top 2%
CA Csl Behring Lengnau Ag: 8 patents #1 of 30Top 4%
AG Aventis Behring Gmbh: 5 patents #5 of 87Top 6%
CL Csl Limited: 1 patents #95 of 176Top 55%
Overall (All Time): #143,414 of 4,157,543Top 4%
27
Patents All Time

Issued Patents All Time

Showing 25 most recent of 27 patents

Patent #TitleCo-InventorsDate
11890327 Truncated von Willebrand factor polypeptides for extravascular administration in the treatment or prophylaxis of a blood coagulation disorder Sabine Pestel, Elmar Raquet 2024-02-06
11814421 Truncated von Willebrand Factor polypeptides for treating hemophilia Stefan Schulte, Sabine Pestel, Hubert Metzner, Steve Dower 2023-11-14
11564976 Methods for preparing modified von Willebrand Factor Stefan Schulte, Hans-Wilhelm Beltz, Sabine Pestel, Matthias Pelzing 2023-01-31
11155601 Modified von Willebrand factor having improved half-life Michael Moses, Stefan Schulte, Gerhard Dickneite, Uwe Kalina, Sabine Pestel 2021-10-26
11141466 Modulation of FVIII immunogenicity by truncated VWF Anne VERHAGEN, Sabine Pestel, Marco Hofmann, Huy Huynh, Eugene Maraskovsky 2021-10-12
10905747 Methods for preparing modified von Willebrand factor Stefan Schulte, Hans-Wilhelm Beltz, Sabine Pestel, Matthias Pelzing 2021-02-02
10772936 Methods for preparing modified von Willebrand factor Stefan Schulte, Hans-Wilhelm Beltz, Sabine Pestel, Matthias Pelzing 2020-09-15
10688157 Truncated von Willebrand factor polypeptides for treating hemophilia Stefan Schulte, Hubert Metzner, Sabine Pestel 2020-06-23
9878017 Covalent complex of von Willebrand Factor and factor VIII, compositions, and uses relating thereto Hubert Metzner, Stefan Schulte 2018-01-30
9458223 Von willebrand factor variants having improved factor VIII binding affinity Stefan Schulte, Kay Hofmann 2016-10-04
9347051 Coagulation factor X polypeptides with modified activation properties Stefan Schulte, Hans-Peter Hauser, Uwe Kalina 2016-05-24
9290561 Factor VIII, von Willebrand factor or complexes thereof with prolonged in vivo half-life Stefan Schulte, Hubert Metzner, Ulrich Kronthaler, Holger Lind, Wiegand Lang 2016-03-22
9249404 Coagulation factor X polypeptides with modified activation properties Stefan Schulte, Hans-Peter Hauser, Uwe Kalina 2016-02-02
8828939 Modified vitamin K dependent polypeptides Stefan Schulte, Kay Hofmann, Hans-Peter Hauser 2014-09-09
8765915 Modified coagulation factor VIIa with extended half-life Stefan Schulte, Ulrich Kronthaler, Wiegand Lang, Uwe Liebing, Wilfried Wormsbacher 2014-07-01
8754194 Modified coagulation factors with prolonged in vivo half-life Stefan Schulte, Hubert Metzner 2014-06-17
8575104 Factor VIII, von willebrand factor or complexes thereof with prolonged in vivo half-life Stefan Schulte, Hubert Metzner, Ulrich Kronthaler, Holger Lind, Wiegand Lang 2013-11-05
8283319 Therapeutic application of Kazal-type serine protease inhibitors Stefan Schulte, Ulrich Kronthaler, Stefan Schmidbauer, Kay Hofmann 2012-10-09
7939632 Proteolytically cleavable fusion proteins with high molar specific activity Hubert Metzner, Stefan Schulte 2011-05-10
7863009 Mutants of the factor VII-activating protease and detection methods using specific antibodies Juergen Roemisch, Hans-Arnold Stoehr, Annette Feussner, Wiegand Lang, Margret Becker +3 more 2011-01-04
7803569 Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations Stefan Kiechl, Johann Willeit, Christian Wiedermann, Juergen Roemisch, Annette Feussner +7 more 2010-09-28
7442514 Mutants of the factor VII-activating protease and detection methods using specific antibodies Juergen Roemisch, Hans-Arnold Stoehr, Annette Feussner, Wiegand Lang, Margret Becker +3 more 2008-10-28
7153679 Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis Stefan Kiechl, Johann Willeit, Christian Wiedermann, Juergen Roemisch, Annette Feussner +7 more 2006-12-26
6831167 Mutants of the factor VII-activating protease and detection methods using specific antibodies Juergen Roemisch, Hans-Arnold Stoehr, Annette Feussner, Wiegand Lang, Margret Becker +2 more 2004-12-14
6573081 Method for growing circoviruses Dieter Bernhardt, Albrecht Groener 2003-06-03